Close
Nordic 9Nordic 9

Glionova (private company)

Sweden glionova.com
See something wrong or missing? Let us know
Offices:Stockholm
Industry:Biotech
Business model:B2B

Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer. The company is engaged in the development of therapies for difficult-to-treat cancers and develops GLN-1001, an orally bioavailable small molecule that induces selective cell death in glioblastoma cells without causing harm to normal brain tissue.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 5.7M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Glionova

Name Criteria
Denmark Antag Therapeutics
38%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Spain Biome Makers
38%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Denmark Chromologics
38%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Finland Desentum
38%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Sweden Elypta
38%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Hungary Turbine
38%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Germany Bluu Bioscience
38%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Lifebit
38%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Ochre Bio
38%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Belgium Antelope Dx
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Top